Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Galantamine for Alzheimer's disease
HTML
Details
Locations
Year:
2010
Type:
review
Source:
Expert Opinion on Drug Metabolism & Toxicology
DOI:
10.1517/17425251003592137
Authors:
David Prvulovic,
Harald Hampel,
Johannes Pantel
Institution:
Goethe University Frankfurt
Language:
English
Topic:
Cholinesterase and Neurodegenerative Diseases
Subfield:
Pharmacology (medical)
Field:
Medicine
Domain:
Health Sciences
Keywords:
galantamine,
Alzheimer's disease,
cholinesterase inhibitors,
cholinergic system,
rivastigmine,
donepezil,
cognitive performance,
activities of daily living,
behavioral symptoms,
drug efficacy and tolerability,
first-line therapy
show all 11
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2155462253
FWCI:
0.654
Cites:
91
Cited by:
124
Related to:
10